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Leptospirosis and haemorrhagic fever with renal syn-
drome (HFRS) are hard to distinguish clinically since 
these two important rodent-borne zoonoses share 
hallmark symptoms such as renal failure and haemor-
rhage. Leptospirosis is caused by infection with a spi-
rochete while HFRS is the result of an infection with 
certain hantaviruses. Both diseases are relatively rare 
in the Netherlands. Increased incidence of HFRS has 
been observed since 2007 in countries that border the 
Netherlands. Since a similar rise in incidence has not 
been registered in the Netherlands, we hypothesise 
that due to overlapping clinical manifestations, han-
tavirus infections may be confused with leptospiro-
sis, leading to underdiagnosis. Therefore, we tested a 
cohort of non-travelling Dutch patients with symptoms 
compatible with leptospirosis, but with a negative 
diagnosis, during 2010 and from April to November 
2011. Sera were screened with pan-hantavirus IgG and 
IgM enzyme-linked immunosorbent assays (ELISAs). 
Sera with IgM reactivity were tested by immunofluo-
rescence assay (IFA). ELISA (IgM positive) and IFA 
results were confirmed using focus reduction neu-
tralisation tests (FRNTs). We found hantavirus-specific 
IgG and/or IgM antibodies in 4.3% (11/255) of samples 
taken in 2010 and in 4.1% (6/146) of the samples dur-
ing the 2011 period. After FRNT confirmation, seven 
patients were classed as having acute Puumala virus 
infections. A review of hantavirus diagnostic requests 
revealed that at least three of the seven confirmed 
acute cases as well as seven probable acute cases of 
hantavirus infection were missed in the Netherlands 
during the study period.  
Introduction
Hantaviruses, negative-stranded RNA viruses belong-
ing to the Bunyaviridae family, can cause severe dis-
ease in humans. Depending on the type of hantavirus, 
either haemorrhagic fever with renal syndrome (HFRS) 
or hantavirus cardiopulmonary syndrome may occur 
after inhalation of virus-containing aerosols [1]. HFRS 
is characterised by acute renal failure, fever (above 
38.5 °C) and potentially accompanied by severe bleed-
ing complications [2]; it is a notifiable disease in the 
Netherlands. HFRS cases are found in large parts 
of Europe and Asia [3]. Pathogenic hantaviruses are 
rodent-borne and each of these viruses are spread by 
a specific rodent species. For the HFRS-causing hanta-
viruses, these include Apodemus, Myodes, Rattus and 
possibly Microtus species [4,5]. The causative agent 
of HFRS known to be endemic in the Netherlands is 
Puumala virus (PUUV), which is spread by its chroni-
cally infected reservoir, the bank vole (Myodes glare-
olus) [6]. Symptomatic cases of PUUV infection may 
develop mild HFRS, often referred to as nephropathia 
epidemica. Recent reports describe PUUV infections 
with a broader clinical spectrum, ranging from mild 
febrile cases, without renal impairment or haemor-
rhage, to severe respiratory manifestations without 
any signs of renal involvement [7,8]. Historically, the 
occurrence of PUUV infection in the Netherlands has 
been restricted to the eastern and southern parts of the 
country, with an incidence of 25–30 cases reported per 
year (approximately 0.04–0.18 cases per 100,000 pop-
ulation) [9]. Since 2007, several studies have described 
an increase in the number of human PUUV infections in 
neighbouring countries at the eastern (Germany) and 
southern borders (Belgium) [10-12]. To date, a similar 
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increase in the number of human PUUV infections has 
not been observed in the Netherlands.
In the early 1990s, Groen et al. tested 8,892 sera 
obtained in the Netherlands from different risk groups, 
such as renal disease patients, and subjects from 
suspected occupational risk groups, such as forestry 
workers and military personnel, for the presence of 
hantavirus antibodies [13]. The highest prevalence (up 
to 6%) was seen in participants with known occupa-
tional risk factors associated with increased rodent 
exposure [13,14]. Data (which are as yet unpublished 
but a summary of the main results is available) from 
a large serum bank study in the Netherlands that 
started in 2006 showed a hantavirus seroprevalence, 
in a cross-sectional population based study, of 1.7% 
[15]. Given that 70–80% of PUUV infections are asymp-
tomatic and that only 5–10% of symptomatic patients 
will probably seek medical attention [16], the 25–30 
cases reported every year in the Netherlands (with a 
population of 16.8 million [17]) are indicative of poten-
tial underdiagnosis of hantavirus infections [4,5]. In 
2011, we described a case report of a patient with 
nephropathia epidemica diagnosed outside the area 
known to be endemic for hantavirus circulation in the 
Netherlands, Overijssel  [18]. Although the patient had 
visited a known PUUV-endemic area, this information 
in the patient history did not result in rapid diagnosis 
of the cause of the disease, illustrating unawareness of 
hantavirus infections.
Leptospira, a genus of helical-shaped bacteria, forms 
another important group of causative agents of rodent-
borne haemorrhagic fever in the Netherlands [19]. 
Pathogenic Leptospira cause leptospirosis, which 
shares many clinical manifestations with HFRS, such as 
renal failure, thrombocytopenia and potential bleeding 
complications [3]. Interestingly, two studies, from Italy 
and Sri Lanka, showed an increased hantavirus sero-
prevalence in patients suspected of having leptospiro-
sis. Compared with control groups consisting of office 
personnel or healthy blood donors, the number of con-
firmed cases of hantavirus infection was significantly 
higher among those who were clinically suspected, by 
a clinician, of having leptospirosis [20,21]. Groen et al. 
reported a hantavirus seroprevalence of about 1% in 
patients suspected of having acute leptospirosis in the 
Netherlands in samples collected between 1972 and 
1994 [13]. The actual prevalence of confirmed acute 
leptospirosis was slightly higher (3%) [13].
In the Netherlands, a relatively low number of lepto-
spirosis cases are registered annually, as are HFRS 
cases, with a reported incidence of 0.25 leptospiro-
sis cases/100,000 population [19]. To investigate the 
putative underdiagnosis of hantavirus infection in 
symptomatic patients, we tested a cohort of leptospi-
rosis-suspected, but confirmed-negative, patients with 
no travel history for the previous three months, for 
the presence of hantavirus-specific antibodies, using 
a two-step strategy: pan-hantavirus enzyme-linked 
Figure 1
Design, inclusion criteria and confirmatory steps of the 
hanta hunting study, the Netherlands, 2010 and April–
November 2011
+ Positive test result
− Negative test result
OD: optical density (an OD of >1.10 was regarded as positive, 
between ≥0.90 and ≤1.10 as equivocal and <0.90 as negative); 
ELISA: enzyme-linked immunosorbent assay; FRNT: focus 
reduction neutralisation test; HNTV: Hantaan virus; IFA: 
immunofluorescence assay; PUUV: Puumala virus.
The rationale for the chosen period was an overall increase in 
hantavirus activity in countries neighbouring the Netherlands 
(Germany and Belgium) (January–December 2010) [4] and the 
known season of PUUV activity in northern and western Europe 
(April–November 2011) [26].
                                                                                                                                                                   
Samples received
for leptospirosis testing
n=1,262
Jan – Dec 2010
n=737 
Apr–Nov 2011
n=525
Sera tested from
leptospirosis-negative,
non-travelling patients
Samples collected 
between ≥2 days 
and ≤28 days
after symptom onset
n=401 
Pan-hantavirus ELISAs
IgG: n=31 with OD ≥0.9 
IgM: n=27 with OD ≥0.9 
27 IgM ELISA-responsive sera
(positive or equivocal)
tested by
PUUV IFA: 9 positive sera
HNTV IFA: 2 positive sera
FRNT confirmed PUUV infection in:
7/8 IgM ELISA+ and PUUV-IFA IgM+
0/2 IgM ELISA+ and HNTV-IFA IgM+
3/3 ELISA IgG+ 
0/7 ELISA IgM+ IFA−
Samples excluded,
as patients did not meet
inclusion criteria
n=861
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immunosorbent assays (ELISAs) followed by two sepa-
rate immunofluorescence assays (IFA): one to detect 
PUUV serogroup antibodies and one to detect  Hantaan 
virus (HNTV) serogroup antibodies (HNTV was used as 
it belongs to the same serogroup as Seoul hantavirus 
(SEOV). Recent evidence indicates the circulation of 
SEOV in Europe [22-24], spread by Rattus norvegicus, 
which is also a well-known carrier of Leptospira [3]).  To 
confirm the ELISA and IFA results, focus reduction neu-
tralisation tests (FRNTs) were used, the gold standard 
technique in hantavirus serology. All IFA IgM-positive 
sera were tested in the FRNT with PUUV virus. In addi-
tion, because recent evidence indicates the circula-
tion of SEOV in Europe, we included SEOV, as well as 
Dobrava virus (DOBV), in the FRNT, although not the 
main aim of this study, to gain insight into the potential 
introduction of these viruses in the Netherlands.
Methods
Serum bank
Sera from non-travelling Dutch patients with a nega-
tive leptospirosis diagnosis – based on a microscopic 
agglutination test (MAT), ELISA and culture performed 
at the National Leptospirosis Reference laboratory 
(NRL) at the Royal Tropical Institute (KIT) in Amsterdam 
– were included in our study. A sample was deemed 
to be negative for leptospirosis if the patient did not 
meet the case definition for leptospirosis – i.e. the in-
house ELISA for leptospirosis was below the cut-off 
titre of 1:80 and the MAT showed no relevant titre of 
Leptospira-specfic antibodies (<1:160) [25]. The study 
cohort was taken from submissions of sera to the NRL 
in 2010, as a large increase in the number of PUUV 
infections in Germany and Belgium were observed 
that year [4]. In addition, we also included sera from 
patients meeting the above inclusion criteria that were 
received by the NRL during April to November 2011, 
the season for PUUV activity in northern and western 
Europe [26] (Figure 1).
As we were interested in patients who had pan-han-
tavirus IgM antibodies, we selected patients whose 
samples had been collected at least two days after 
symptom onset, up to four weeks (28 days) after 
symptom onset. All samples were heat inactivated (30 
minutes at 56 °C) and stored at −20 °C until testing. 
Requests for leptospirosis testing were accompanied 
by a standardised form with information about place 
of residence, travel history, presenting symptoms and 
occupation: these data were reviewed.
Hantavirus underdiagnosis was assessed by checking 
if testing for hantavirus was requested at either of the 
hantavirus diagnostic laboratories in the Netherlands 
(Erasmus MC in Rotterdam and RIVM in Bilthoven) 
for any of the pan-hantavirus ELISA-responsive sera 
(equivocal or positive result in an IgG or IgM ELISA).
Patients whose sera were responsive in any of the diag-
nostic tests were ranked by likelihood of hantavirus 
infection. Patients whose sera were positive in the IgM 
ELISA, IFA and FRNT were considered a confirmed case 
of acute hantavirus infection. If only the IgM ELISA was 
positive (or equivocal) and IFA was positive, the patient 
was considered a probable acute case.  If only the IgG 
ELISA was positive and therefore IFA was not per-
formed, but the FRNT was positive for PUUV, the patient 
was also considered a probable acute case. If only the 
IgM ELISA was positive or equivocal, the patient was 
considered not a case of hantavirus infection.
Enzyme-linked immunosorbent assay
Sera were screened using pan-hantavirus IgG and IgM 
DxSelect ELISAs (Focus Diagnostics). These ELISAs 
are used for testing a broad range of hantaviruses, 
although there are variations in sensitivity and speci-
ficity per specific hantavirus. According to the material 
supplied by the manufacturer, the IgM test has an over-
all sensitivity of 95.1% (83.5–99.4%) and a specificity 
of 94.1% (83.8–98.8%). The IgG test has comparable 
performance characteristics, with an overall specific-
ity of 95% (91.4–100%) and a sensitivity of 95% (75–
98%); both tests are compared with a reference ELISA 
by external investigators. For the Netherlands, the 
performance of these ELISAs in detecting antibodies 
to PUUV and, potentially, SEOV, is of importance. Data 
supplied by the manufacturer showed a sensitivity of 
70% (45.7–88.1%) in the IgM ELISA and 95% (83.2–
100%) in the IgG ELISA for PUUV-specific antibodies, as 
tested by FRNT. For SEOV FRNT-positive samples, the 
sensitivity was 50% (11.8–88.2%) in the IgM ELISA and 
95% (54.1–100%) in the IgG ELISA. 
An optical density (OD) of >1.10 was regarded as posi-
tive, between ≥0.90 and ≤1.10 as equivocal and <0.90 
as negative.
Immunofluorescence assay
ELISA IgM-positive or equivocal sera were tested in 
IFA by using commercial slides with PUUV- and HNTV-
infected cells (PROGEN Biotechnik). Only IgM-reactive 
samples were chosen as these are indicative of a 
recent infection, possibly related to the clinical symp-
toms that were the basis of the initial request for lep-
tospirosis testing. IFA was used because of its higher 
reported specificity and the possibility of being able 
to distinguish between PUUV- or HTNV-like serotype 
infections (manufacturer’s insert, PROGEN Biotechnik). 
Before testing, the sera were incubated with liver ace-
tone powder from calves (Sigma-Aldrich, Germany) 
to reduce background fluorescence. For the IgM test, 
the sera were pretreated with GullSORB (Meridian 
Bioscience Inc., United States) to reduce isotype com-
petition. Sera were serially diluted twofold starting at 
1:32 and incubated on the slides for 1 hour at 37 °C. 
After this step, the wells were incubated with either 
a fluorescein isothiocyanate (FITC)-labelled goat anti-
human IgG or IgM conjugate. Fluorescence was scored 
under an immunofluorescence microscope. The cut-off 
titre for a positive result was defined as the sample 
dilution for which specific fluorescence was greater 
4 www.eurosurveillance.org
than the sample dilution for which specific fluores-
cence was just identifiable: in this study, it was >1:64.
Focus reduction neutralisation test
All samples positive in the pan-hantavirus IgM ELISA 
and PUUV IgM IFA were selected for FRNT confirmation 
(samples 4, 7, 10, 11, 12, 14, 19, 21 and 22).  We also 
selected two samples positive or equivocal in the pan-
hantavirus IgM ELISA and positive in the IgM HNTV IFA 
for FRNT (samples 5 and 6). In addition, eight samples 
that were positive in the IgM ELISA but negative in the 
IFAs were also selected for FRNT (samples 2, 3, 9, 13, 
15, 17, 18 and 20). As a fourth category, three samples 
that had not been included in the IFA analysis (as they 
were ELISA IgM negative), but that tested positive in 
the IgG ELISA (samples 1,8 and 16), were selected for 
FRNT confirmation.
FRNTs for DOBV strain Slovenia, SEOV strain 80-39 
and PUUV strain Kazaan were carried out as described 
elsewhere [27]. Diluted sera were mixed with an equal 
volume of diluted virus containing 30–70 focus-form-
ing units/100 µl. The serum end-concentration was 
1:40. The mixture was incubated at 37 °C for 1 hour 
and subsequently inoculated into wells of six-well tis-
sue culture plates containing confluent Vero E6 cell 
Table 1
Serological test results from samples selected for focus reduction neutralisation test confirmation of hantavirus infection, 
the Netherlands, 2010 and April–November 2011 (n=22)
Sample 
number
Date of 
sampling
ELISAa IFAb FRNTc Acute hantavirus 
infection
case statusIgM IgG
PUUV
IgM
PUUV
IgG
HNTV
IgM
HNTV
IgG PUUV SEOV DOBV
PUUV IFA IgM positive
4 May 2010 POS POS 1:128 1:128 NEG 1:128 POS NEG NEG Confirmed
7 Jul 2010 POS POS 1:128 1:128 1:128 NEG POS NEG NEG Confirmed
10 Aug 2010 POS POS 1:128 1:128 NEG 1:128 POS NEG NEG Confirmed
11 Aug 2010 POS POS 1:128 1:128 NEG NEG POS NEG NEG Confirmed.
12 Aug 2010 POS Equi 1:128 1:128 NEG NEG POS NEG NEG Confirmed.
14 Aug 2010 POS NEG 1:128 1:128 NEG NEG NEG NEG NEG Probable
19 Jul 2011 POS POS 1:128 1:128 1:128 1:128 POS NEG NEG Confirmed
21 Sep 2011 POS NEG 1:128 1:128 NEG NEG NS NS NS Probable
22 Sep 2011 POS Equi 1:128 1:128 1:128 1:128 POS NEG NEG Confirmed
HNTV IFA IgM positive and ELISA IgM reactive
6 Jun 2010 POS POS NEG NEG 1:512 1:512 NEG NEG NEG Probable
5 Jun 2010 Equi NEG NEG NEG 1:128 NEG NEG NEG NEG Probable
ELISA IgM reactive and PUUV or HNTV IFA negative
2 Feb 2010 POS NEG NEG NEG NEG NEG NEG NEG NEG Not a case
3 Feb 2010 POS NEG NEG NEG NEG NEG NEG NEG NEG Not a case
13 Aug 2010 POS NEG NEG NEG NEG NEG NEG NEG NEG Not a case
15 Oct 2010 POS NEG NEG NEG NEG NEG NEG NEG NEG Not a case
17 May 2011 POS NEG NEG NEG NEG NEG NEG NEG NEG Not a case
18 Jul 2011 POS POS NEG NEG NEG NEG NEG NEG NEG Not a case
20 Aug 2011 POS NEG NEG NEG NEG NEG NEG NEG NEG Not a case
9 Jul 2010 Equi POS NEG NEG NEG NEG NS NS NS Not a case
Not tested by IFA (as ELISA IgM negative), but ELISA IgG positive
1 Feb 2010 NEG POS NT NT NT NT POS NEG NEG Probabled
8 Jul 2010 NEG POS NT NT NT NT POS NEG NEG Probabled
16 Apr 2011 NEG POS NT NT NT NT POS NEG NEG Probabled
DOBV: Dobrava virus; ELISA: enzyme-linked immunosorbent assay; Equi: equivocal; FRNT:  focus reduction neutralisation test; HTNV G: 
Hantaan virus; IFA: immunofluorescence assay; NEG: negative; NS: insufficient amount of serum; NT: not tested in IFA (samples not 
responsive in the IgM ELISA were not tested by IFA); POS: positive; PUUV: Puumala virus; SEOV: Seoul virus.
a  ELISA results were scored as positive if OD >1.10,equivocal if between ≥0.90 and ≤1.10  and negative if <0.90. 
b  The IFA was scored positive when the reactive titres were >1:64. 
c  The FRNT was scored positive with a cut-off of 80% virus neutralisation. 
d  IgM antibodies were not detected in these samples, but as hantavirus infection was confirmed by FRNT, the patients were still scored as 
probable acute hantavirus cases. 
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monolayers. The wells were overlaid with a mixture of 
agarose and tissue culture medium and incubated for 
7–13 days. The agarose was removed from the wells 
and the cells were fixed. For PUUV-infected cells, 
polyclonal macaque serum [28] was used as the pri-
mary antibody and the monoclonal antibody 1C12 for 
DOBV- and SEOV-infected cells as described elsewhere 
[29]. This step was followed by adding peroxidase-
labelled goat-anti-human IgG for the macaque serum 
and goat-anti-mouse IgG for the 1C12 monoclonal 
antibody to the cells, to indicate virus-infected cells. 
Tetramethylbenzidine was used as substrate and foci 
were counted. An 80% reduction in the number of foci, 
compared with the virus control, was used as the crite-
rion for virus neutralisation titres.
Review of hantavirus diagnostic requests 
carried out during suspicion of leptospirosis at 
the time of sampling
All samples responsive in the IgM and/or IgG pan-han-
tavirus ELISA were checked for patient-specific charac-
teristics (sex and date of birth). The combination of sex 
and date of birth was checked in the databases of the 
hantavirus diagnostic laboratories in the Netherlands. 
If the sample combination matched the information 
from the database and the diagnostic request was 
made in 2010 or 2011, the patient was scored as hav-
ing been adequately diagnosed for hantavirus disease 
during the onset of their symptoms. If the sex and date 
of birth combination could not be found in the data-
bases, but the patient’s sample was reactive in any of 
our tests, the case was scored as a missed probable or 
confirmed hantavirus case, as described in the serum 
bank section above.  
Ethical issues
This study was exempted from ethical review of 
human subject research by the Medical Ethical 
Review Committee of the Erasmus MC Medical Centre, 
University of Rotterdam. All data have been anonymised 
and are not attributable to individual patients.
Results
Enzyme-linked immunosorbent assay and 
immunofluorescence assay serology
Of the 1,262 samples received for leptospirosis diag-
nostic testing during January– December 2010 and 
April–November 2011, 861 were excluded, as the 
patients did not meet the inclusion criteria of our study.
All selected and available sera (n=401) were tested by 
pan-hantavirus ELISAs. Overall, the IgG ELISA resulted 
in 18 positive and 13 equivocal samples. The IgM test-
ing resulted in 17 positive and 10 equivocal samples. 
A total of 11 samples reacted in both the IgG and IgM 
ELISAs, bringing the total number of samples that 
responded in both ELISAs to 47, i.e. 11.7% of the 401 
samples (4.3% (11/255) of samples taken in 2010 and 
4.1% (6/146) of the samples taken in 2011).
Subsequently, the 27 samples with a positive or equiv-
ocal response in the IgM ELISA were tested using both 
PUUV and HTNV IFAs. In total, nine of the 27 IgM ELISA-
responsive samples tested positive for both PUUV IgM 
and IgG by IFA.
Interestingly, two serum samples were positive in 
the HTNV IFA, but negative in the PUUV IFA, despite 
repeated PUUV testing. One of the HTNV-positive sam-
ples tested positive for both HNTV IgG and IgM with 
titres of 1:512; the other sample was positive only for 
HNTV IgM, with a titre of 1:128.
Confirmation by focus reduction neutralisation 
test
FRNT was performed on eight of the nine sera with a 
positive IgM response in the PUUV IFA (there was an 
insufficient amount of serum in the ninth sample). It 
confirmed that seven of the eight samples tested were 
from patients with recent PUUV infections (samples 4, 
7, 10, 11, 12, 19 and 22) (Table 1).
We also tested the two sera with an HNTV IgM-positive 
IFA and a positive or equivocal ELISA IgM response 
(samples 5 and 6): both sera were negative by FRNT.
To test if cases had been missed due to lack of sensi-
tivity of the IFAs, we selected eight samples, of which 
seven samples had enough serum left for FRNT, with 
only IgM reactivity in the ELISAs and a negative PUUV 
or HNTV IFA (samples 2, 3, 13, 15, 17, 18 and 20): all 
seven samples were negative by FRNT.
We also selected three samples that had not been 
included in the IFA analysis (as they were ELISA IgM 
negative), but that tested positive in the IgG ELISA 
(Cases 1,8 and 16). These samples were tested by 
FRNT because there was a high degree of suspicion of 
PUUV infection based on the application form for lep-
tospirosis diagnostic request sent by the clinician (e.g. 
recorded renal failure and possible rodent exposure). 
All three patients had a long duration of their com-
plaints (more than three weeks since symptom onset, 
making it possible that hantavirus disease, without 
the detection of IgM antibodies, was the cause of their 
symptoms. All three were positive in the PUUV FRNT.
Thus in total, FRNT for PUUV, SEOV and DOBV was per-
formed on 20 of the 22 selected samples, due to an 
insufficient amount of serum in two samples. Of the 20 
serum samples tested, 10 were confirmed as PUUV pos-
itive, seven of which were considered due to a recent 
infection, based on the presence of IgM antibodies.
Patient characteristics and registered clinical 
signs and symptoms in confirmed cases
Because of the retrospective nature of our study, we 
could confirm if patients had been adequately tested 
for hantavirus infection during their disease course or 
if the patient was a missed case of PUUV infection. Of 
the 27 samples with at least an equivocal response in 
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the IgM ELISA in our study, which would necessitate 
further testing of a follow-up serum sample, four were 
adequately tested by routine serology for hantavirus 
infection at diagnostic centres at the time of sampling 
during suspicion of leptospirosis (samples 4, 10, 11 and 
12).
The two samples that were responsive in the ELISAs 
and HNTV IFA, but not in FRNT (samples 5 and 6), were 
not tested for hantavirus antibodies by ELISA or IFA at 
the time the patients were sampled.
All available information from retroactively determined 
probable or confirmed cases of hantavirus infection 
that were not tested for hantavirus infection during 
suspicion of leptospirosis at the time of sampling is 
shown in Table 2. In general, most of the cases were 
in the eastern parts of the Netherlands. Newly recog-
nised areas with confirmed cases were in the north-
ern province of Groningen and the western province 
of Zuid-Holland. The missed confirmed and probable 
cases of hantavirus infection are shown in Figure 2 
according to the location of sampling, ranked by like-
lihood of hantavirus infection, with the highest level 
of evidence being that of a sample with a positive 
response in the IgM ELISA confirmed by IFA (IgM and 
IgG) tests and a positive FRNT result.
Discussion
In the samples tested, a positive response of hantavi-
rus IgM antibodies in the ELISA was observed in 4.3% 
(11/255) of samples taken in 2010 and 4.1% (6/146) of 
the samples taken in 2011. When including samples 
with an equivocal ELISA result, the overall percentage 
with an IgM response was 6.7% (27/401). Confirmation 
with IFA IgM resulted in a 2.7% (11/401) seropositivity in 
the cohort. Of these 11 samples, seven were confirmed 
by FRNT, corresponding to an overall seropositivity 
in the cohort of almost 2%. However, this percentage 
could very well be an underestimation. For instance, 
Table 2
Information on cases of hantavirus infection undiagnosed at time of sampling during suspicion of leptospirosis, the 
Netherlands, 2010 and April–November 2011
Sample 
number
Date of 
request for 
leptospirosis 
testing
Sex
Age group 
in years State
Information at time 
of request for 
leptospirosis testing 
Retroactive hantavirus diagnostic 
test results
Acute 
hantavirus 
infection
case statusELISAa IFAb FRNTc
16 Apr 2011 M 20–24 Overijssel Acute kidney failure and hepatitis IgG + NT PUUV + Probable
1 Feb 2010 M 20–24 Overijssel Prolonged severe disease IgG + NT PUUV + Probable
8 Jul 2010 M 10–14 Groningen
Contact with soil water 
and potential rodent 
exposure
IgM Equi 
IgG + 
PUUV −
HNTV − PUUV + Probable
21 Sep 2011 F 25–30 Overijssel Icteric; non-responsiveto antibiotics IgM + PUUV IgM + NS Probable
14 Aug 2010 F 20–24 Zuid-Holland No additional information IgM + PUUV IgM + All − Probable
5 Jun 2010 M 20–24 Limburg No additional information IgM + HNTV IgM + All − Probable
6 Jun 2010 M 25–30 Gelderland
Emergency hospital 
admission,  
to an intensive-care unit
IgM + 
IgG +
HNTV IgM + 
HNTV IgG + All − Probable
22 Sep 2011 M 45–49 Gelderland Clinical picture not understood
IgM + 
IgG +
PUUV IgM + 
PUUV IgG + PUUV + Confirmed
19 Jul 2011 M 50–54 Groningen Extreme tiredness, feverand diarrhoea
IgM + 
IgG +
PUUV IgM + 
PUUV IgG + PUUV + Confirmed
7 Jul 2010 M 35–39 Noord-Brabant
Severe disease with high 
fever and emergency 
hospital admission
IgM + 
IgG +
PUUV IgM + 
PUUV IgG + PUUV + Confirmed
+ Positive test result
− Negative test result
DOBV: Dobrava virus; ELISA: Enzyme-linked immunosorbent assay; EQUI: equivocal; F: female; FRNT: focus reduction neutralisation test; 
HNTV: Hantaan virus; IFA: immunofluorescence assay; M: male; NS: insufficient amount of serum; NT: not tested in IFA (samples not 
responsive in the IgM ELISA were not tested by IFA); PUUV: Puumala virus; SEOV: Seoul virus. 
a ELISAs for pan-hantavirus IgM and IgG antibodies were used. 
b For IFA, both PUUV and HNTV sergroups were used.
c For FRNT, PUUV, SEOV and DOBV were used.
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one sample could not be confirmed by FRNT due to 
a lack of available serum after ELISA and IFA screen-
ing. It is conceivable that in our cohort of symptomatic 
patients, of the seven confirmed hantavirus diagnoses, 
at least three cases were not adequately diagnosed at 
the time of disease (Cases 7, 19 and 22). The other four 
confirmed cases were found in the databases of the 
hantavirus diagnostic centres in the Netherlands, and 
thus were adequately diagnosed at the time of disease. 
We also identified seven probable cases of acute han-
tavirus infection: we consider that hantavirus infection 
was a highly plausible explanation for their symptoms, 
but either FRNT confirmation was not performed due 
to the lack of serum or the presence of IgM antibod-
ies (confirming acute infection) could not be proved by 
ELISA and IFA.
All samples confirmed by FRNT (n=10) only showed 
PUUV-neutralising activity. The vector of this hantavi-
rus is Myodes glareoulus (bank vole), a small, reddish 
rodent that inhabits large parts of the Netherlands, 
solely in grasslands and forests [9]. Case 6, with high 
OD values in IgM and IgG ELISA screening and a posi-
tive HNTV IFA, did not neutralise PUUV, DOBV or SEOV.
This study revealed a high seroprevalence of about 2% 
of hantavirus antibodies in a cohort of leptospirosis-
suspected patients who tested negative for leptospi-
rosis. Leptospirosis in the Netherlands may be either 
endemic or imported [19]. In our cohort, travel history 
was well documented and hence we consider it quite 
certain that the patients we studied contracted hanta-
viruses in the Netherlands.
Figure 2
Distribution of probable and confirmed cases of hantavirus infection in the Netherlands, 2010 and April–November 2011 
(n=14)
The star marks the capital, Amsterdam.
This figure shows the probable and confirmed cases of acute hantavirus infection in the Netherlands and if they were adequately diagnosed 
during their illness or if these were ‘missed’ cases. The cases are ranked by likelihood of hantavirus infection. A confirmed case of acute 
hantavirus infection being that of a positive IgG and IgM response in both pan-hantavirus enzyme-linked immunosorbent assay (ELISA) 
and immunofluoresence assay (IFA) and a positive result in the focus reduction neutralisation test (FRNT). A probable case is strongly 
suggestive of an acute case of hantavirus based on ELISA, IFA or FRNT results, but either the FRNT was negative or we were unable to show 
the presence of IgM antibodies.
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This cohort also gave us the opportunity to study the 
circulation of hantaviruses other than PUUV in The 
Netherlands. It is important to monitor this, since 
evidence is mounting of an increase in the number of 
SEOV infections in Europe and worldwide, with a recent 
case reported in the United Kingdom [30]. However, in 
the samples tested from the Netherlands, the SEOV 
FRNT was negative. Results were also not indicative for 
infections with DOBV, which is vectored by the yellow-
necked mouse (Apodemus flavicollis). It is possible 
that the ELISA and IFA results in samples 5 and 6 were 
false positives. The specificity of the ELISA and IFA is 
below 100%, resulting in a (small) chance of cross-
reactivity. Test specifications of the ELISA test showed 
no known cross-reactive pathogens, but this presump-
tion is based on results from very small serum cohorts 
(manufacturer’s insert). Although SEOV and DOBV have 
been excluded as the causative agents in our study, 
the remaining hantaviruses in the HNTV serogroup are 
vectored by reservoir species not known to be present 
in the Netherlands.  Thus, while we cannot rule out the 
possibility that other hantaviruses from the HNTV sero-
group caused the disease in patients from whom sam-
ples 5 and 6 were obtained, with no travel history, this 
remains highly unlikely.
Our results show quite a large discrepancy between 
the initial ELISA screening, followed by IFA analysis and 
eventual gold standard FRNT confirmation. Samples 
that tested positive only in the IgM ELISA (n=7) were 
not confirmed positive by FRNT.  In most cases (7/9), a 
positive response in the IgM pan-hantavirus ELISA in 
combination with a positive result in the PUUV IgM IFA 
was later confirmed by FRNT (sample 14 tested nega-
tive in the FRNT and sample 21 could not be tested). 
Therefore, we underline the importance of FRNT vali-
dation in epidemiological studies before drawing any 
major conclusions, particularly since hantavirus serol-
ogy is highly prone to giving false-positive results [31].
Acute leptospirosis and HFRS share many clinical 
manifestations and certain epidemiological features. 
Exposure to rodents is a known risk factor for both 
diseases. Hallmark symptoms in both HFRS and lepto-
spirosis include kidney failure. Two of the four cases 
who were diagnosed at the time of their disease course 
had documented kidney disorders (data not shown). 
However, of the 10 cases who were not diagnosed, only 
one (sample 16) had documented kidney failure. Of the 
other nine undiagnosed cases, one was described as 
having ‘high fever’ (sample 7), two as having ‘severe 
disease’ (samples 1 and 7) and one as ‘clinical picture 
not understood’ (sample 22): the fact that these cases 
were undiagnosed in the Netherlands during their dis-
ease course could be due to a potential lack of typi-
cal presenting symptoms for hantavirus disease in the 
Netherlands, meaning the absence of kidney failure. 
Hepatic involvement, often present in leptospirosis – 
one of the classic triads in Weil’s disease [3] – could 
lead a clinician to think of leptospirosis, while not 
considering PUUV infection: this would have applied to 
the patient with hepatitis (sample 16), a probable case 
of acute hantavirus infection in our study. Atypical 
presentation of HFRS, as seen in some of the cases 
listed in Table 2 (samples 21 and 19), has been the sub-
ject of several recent case reports [7,32,33]. However, 
unawareness and/or lack of clinicians’ knowledge of 
how to recognise hantavirus disease could also be a 
reason for underdiagnosis.
Cases may also be underdiagnosed if the patients 
are outside the hantavirus-endemic area in the 
Netherlands. Such cases might not be identified due to 
the low, but clinically important number of infections, 
resulting in lack of awareness of the clinicians in these 
areas. If we compare the distribution of the previously 
undiagnosed cases in our cohort with the earlier sero-
logical data, for instance, data published by Groen et 
al. [14], 7 of 10 cases of hantavirus infection not tested 
at the time of sampling for hantavirus disease (listed 
in Table 2) were from outside the known endemic area. 
Our conclusions regarding underdiagnosis are sup-
ported by a recent study showing 1.7% hantavirus 
seroprevalence in the Dutch population, which should 
lead to more symptomatic cases than the 25–30 cases 
reported annually [15].
In this relatively small cohort with specific clinical 
indications for leptospirosis diagnostics, we have 
shown the presence of undiagnosed hantavirus cases. 
Leptospirosis itself is potentially an often-missed diag-
nosis in the Netherlands, due to unawareness [19]. 
It is conceivable that physicians, who do not include 
leptospirosis in their differential diagnosis, are even 
less aware of the possibility of hantavirus infections. 
Vice versa, it cannot be excluded that clinicians who 
are aware of hantavirus infections might miss poten-
tial leptospirosis. This hypothesis could be validated 
by performing larger-scale serological studies with 
broader cohorts, comprising patients who are sus-
pected of having leptospirosis or hantavirus infection.
On the basis of the results in this paper, we feel it is 
important to increase awareness of hantavirus infec-
tion in the Netherlands. The increased incidence of 
hantavirus infections in Europe in recent years makes 
this even more important. This increase is affected by 
a multitude of factors. Some, such as changes in land-
scape architecture (e.g. (de)forestation, fragmentation 
of land by motorways, railways and agriculture and 
available burrow space) and increased food availability 
for the rodent reservoirs, are beneficial for the spread 
of hantaviruses [12]. The introduction or discovery of 
new hantavirus strains in Europe has been documented 
[23] and presents another major concern, necessitating 
epidemiological monitoring of vectors and patients. We 
advise that hantavirus and leptospirosis diagnostics 
should be considered for every patient with an undiffer-
entiated fever in any area with potential rodent-borne 
infections, including typing of the causative agents if 
the results are positive.
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By decreasing the unnecessary use of antibiotics [34] 
and providing clinicians with an accurate prediction of 
the disease course and a choice of adequate biomark-
ers of disease severity [3], the identification of hanta-
virus infections might have a limited, but important, 
clinical importance. Furthermore, adequately diagnos-
ing and typing hantavirus infections is of major pub-
lic health importance in order to correctly identify and 
educate risk groups and to design tailor-made preven-
tion programmes, such as rodent-control programmes 
and changes to landscape architecture. 
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